YI

111 Inc
NASDAQHEALTHCAREMEDICAL DISTRIBUTION

Key Statistics

Market Cap
$35.89M
P/E Ratio
EPS
$-7.91
Beta
0.63
52W High
$8.53
52W Low
$2.48
50-Day MA
$5.18
200-Day MA
$5.27
Dividend Yield
Profit Margin
-0.75%
Forward P/E
PEG Ratio

About 111 Inc

111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. The company is headquartered in Shanghai, the People's Republic of China.

Official WebsiteChinaFY End: December

Fundamentals

Revenue (TTM)$11.39B
Gross Profit (TTM)$341.39M
EBITDA$-11.93M
Operating Margin-0.85%
Return on Equity-14.80%
Return on Assets-0.62%
Revenue/Share (TTM)$1303.60
Book Value$-11.78
Price-to-Book17.66
Price-to-Sales (TTM)0.00
EV/Revenue0.021
EV/EBITDA0.08
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-33.10%
Shares Outstanding$5.20M
Float$4.61M
% Insiders8.36%
% Institutions0.35%

Historical Volatility

HV 10-Day
63.51%
HV 20-Day
112.53%
HV 30-Day
99.15%
HV 60-Day
80.30%
HV Rank
82.9%

Volatility is currently contracting

Latest News

111, Inc. Announces First Quarter 2026 Unaudited Financial Results

Continuing Transition toward a More Asset-Light and Operationally Efficient Business Model Net Revenue of Promotional Products (1) Increased by 70.2% and Gross Profit Rose by 75.0% Year-over-Year Total Marketplace (MP) Service Revenue Increased by 24.7% Year-over-Year Fulfillment Expenses as a Percentage of Revenue Improved by 10 Basis Points Year-over-Year SHANGHAI, June 4, 2026 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights Net revenue amounted to RMB2.4 billion (US$342.4 million), representing a 33.1% decrease from RMB3.5 billion in the prior-year quarter.

PRNewsWire6/4/2026Neutral
111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Continuing Transition to an Asset-Light Business Model to Improve Overall Efficiency Delivered Non-GAAP Operating Profitability in Both Q4'25 and FY'25 Generated Positive Operating Cash Flow for Both Q4'25 and FY'25 Continued Gross Profit Margin Expansion for B2B Business in Both Q4'25 and FY'25 SHANGHAI, April 9, 2026 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. 2025 Executing Strategic Optimization: Embraces Asset-Light Partnership Network Growth In 2025, the Company proactively implemented strategic structural optimization by divesting its 100% equity interests in several subsidiaries.

PRNewsWire4/9/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026